文献速递支持与姑息治疗

白癜风患者内脏恶性肿瘤风险显著降低:一项全国性人群队列研究

Markedly Reduced Risk of Internal Malignancies in Patients With Vitiligo: A Nationwide Population-Based Cohort Study.
PubMed 文献 · J Clin Oncol · 2019-02-20

该研究利用韩国国民健康保险理赔数据库(2007年1月至2016年12月),纳入101,078例白癜风患者及202,156例年龄性别频数匹配的对照。调整年龄、性别和合并症后,白癜风组整体内脏恶性肿瘤风险显著降低(HR 0.86,95%CI 0.82-0.89,P<.001),结直肠癌、卵巢癌和肺癌风险亦显著降低。

要点

  • 白癜风患者整体内脏恶性肿瘤风险显著低于无白癜风对照(HR 0.86,95%CI 0.82-0.89,P<.001)。
  • 结直肠癌(HR 0.62,95%CI 0.55-0.69)、卵巢癌(HR 0.62,95%CI 0.46-0.83)和肺癌(HR 0.75,95%CI 0.65-0.86)风险显著降低,P均<.001。
  • 作者认为包括白癜风在内的自身免疫病可能对靶器官以外提供癌症免疫监视。

核心结论

  • 白癜风与整体内脏恶性肿瘤风险降低相关。
  • 作者认为包括白癜风在内的自身免疫病可能对靶器官以外的癌症发生提供免疫监视。

研究设计与样本

  • 基于韩国国民健康保险理赔数据库(2007年1月至2016年12月)的全国性人群回顾性队列研究。
  • 纳入2009年至2016年间至少两次就诊且主要诊断为白癜风的20岁及以上患者(白癜风组)。
  • 对照按年龄和性别频数匹配、每例白癜风患者随机选取2例(对照组),共纳入101,078例白癜风患者和202,156例无白癜风对照。

主要发现

  • 内脏恶性肿瘤发病率在白癜风组为612.9/10万人年,对照组为708.9/10万人年。
  • 调整年龄、性别和合并症后,白癜风组整体内脏恶性肿瘤风险较无白癜风对照显著降低(HR 0.86,95%CI 0.82-0.89,P<.001)。
  • 结直肠癌风险显著降低(HR 0.62,95%CI 0.55-0.69,P<.001)。
  • 卵巢癌风险显著降低(HR 0.62,95%CI 0.46-0.83,P<.001)。
  • 肺癌风险显著降低(HR 0.75,95%CI 0.65-0.86,P<.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Recent studies indicated that the autoimmunity of vitiligo exerts effects on cells other than melanocytes, which confer reduced risks of both melanoma and nonmelanoma skin cancers in patients with vitiligo. However, the risk of internal malignancy in patients with vitiligo has not been elucidated. PATIENTS AND METHODS: We conducted a population-based retrospective cohort study using data from the Korean National Health Insurance claims database obtained from January 2007 to December 2016. All patients age 20 years or older with vitiligo who had at least two contacts with a physician from 2009 to 2016, during which a principal diagnosis was made, were identified (vitiligo group). Controls were randomly selected (two per patient with vitiligo) after frequency matching with the vitiligo group for age and sex during the same period (control group). RESULTS: A total of 101,078 patients with vitiligo and 202,156 controls without vitiligo were included. The incidence rates of internal malignancies were 612.9 and 708.9 per 100,000 person-years in the vitiligo and control groups, respectively. Patients with vitiligo showed a significantly reduced risk of overall internal malignancies (hazard ratio [HR], 0.86; 95% CI, 0.82 to 0.89; P < .001) compared with controls without vitiligo after adjustments for age, sex, and comorbidities. With regard to organ-specific malignancies, patients with vitiligo showed a remarkably decreased risk of cancer in the colon and rectum (HR, 0.62; 95% CI, 0.55 to 0.69; P < .001), ovary (HR, 0.62; 95% CI, 0.46 to 0.83; P < .001), and lung (HR, 0.75; 95% CI, 0.65 to 0.86; P < .001). CONCLUSION: Vitiligo was associated with a reduced risk of overall internal malignancies. These findings suggest that autoimmune diseases, including vitiligo, may provide immune surveillance for the development of cancer beyond the targeted organ.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Bae JM, Chung KY, Yun SJ, et al. Markedly Reduced Risk of Internal Malignancies in Patients With Vitiligo: A Nationwide Population-Based Cohort Study. J Clin Oncol. 2019. PMID: 30785828. doi:10.1200/JCO.18.01223

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。